R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment.

HTA RWE health technology assessment real-world evidence reimbursement

Journal

Journal of comparative effectiveness research
ISSN: 2042-6313
Titre abrégé: J Comp Eff Res
Pays: England
ID NLM: 101577308

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 7 5 2021
medline: 9 7 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

Highlighting the latest developments in both real-world evidence as it relates to health technology assessment and acceptance of real-world evidence by health technology assessment agencies.

Identifiants

pubmed: 33955236
doi: 10.2217/cer-2021-0098
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

797-799

Auteurs

Alex Simpson (A)

Global Access, F Hoffmann-La Roche, Basel, Switzerland.

Sreeram V Ramagopalan (SV)

Global Access, F Hoffmann-La Roche, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH